The MyHealth study showed nurse-led visits significantly improved multiple outcomes over regular physician-led visits. The AMBER study investigated sleep health, sleep quality, and physical and mental well-being in more than 1,400 patients. Researchers compared outcomes in patients who received radiotherapy and those who omitted radiotherapy in the PROSPECT trial. Researchers developed the OASIS breast tissue repository and a classifier system to characterize samples. The program aimed to expand cancer screening programs to provide “community-based, whole human, personalized navigation." The program, called START: Survive, Thrive and Recover Together, is led by oncology nurse navigators. A team adopted a set of standards to “streamline workflows and maximize efficiencies.” Any new patient appointment outside of the 72-hour criteria was managed by a nurse navigator who helped find an earlier time. Transitions of care due to a hospital or clinic closure can “significantly impact” patients with cancer. The absence of a standardized referral bridge from the emergency department can exacerbate inequities in health care access. Developing additional disease-specific pathways “could impact confidence and understanding for other disease sites.” Researchers conducted a comprehensive review to assess the current state of patient experiences at a cancer center. The goal of the study was to “gain a deeper understanding of patient and caregiver experiences” with the resource center. Researchers surveyed patients using the HealthTree Cure Hub, which is a patient-driven clinical cancer information platform. Researchers evaluated if ONN-led education could help survivors of cancer get involved with survivorship programs. Nurse navigators used a digital patient engagement platform to promote patient activation and evaluate outcomes. To date in 2023, the program has provided free education and services to nearly 1,500 callers. Under the cancer concierge service, new patient referrals were sent to the service through telecommunications or EMRs. Researchers surveyed patients with multiple myeloma to gain insights into their decision-making process. Josie Montegaard, NP, who spoke about CLL at JADPRO Live 2023, discusses how she hopes to see the field move forward.